Lindbrook Capital, LLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$885
+55.8%
99
+167.6%
0.00%
Q2 2023$568
-88.6%
37
-83.4%
0.00%
-100.0%
Q3 2022$5,000
-86.1%
223
-85.1%
0.00%
-88.9%
Q3 2021$36,0001,5000.01%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,084,300$15,820,0003.32%
ARMISTICE CAPITAL, LLC 5,748,000$83,863,0001.50%
RA Capital Management 5,614,428$81,915,0001.32%
Krensavage Asset Management, LLC 140,000$2,043,0000.69%
CM Management, LLC 60,000$875,0000.63%
Altium Capital Management LP 170,484$2,487,0000.58%
HighVista Strategies LLC 53,498$781,0000.55%
Sio Capital Management, LLC 150,000$2,189,0000.54%
MANGROVE PARTNERS IM, LLC 295,037$4,305,0000.44%
Rock Springs Capital Management LP 1,494,164$21,800,0000.43%
View complete list of TRAVERE THERAPEUTICS INC shareholders